DOI:
10.1055/s-00000099
Zeitschrift für Orthopädie und Unfallchirurgie
LinksClose Window
References
Liu L, Zhao N, Xu W. et al.
Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma.
J Hematol Oncol 2016;
9: 54
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.